Pharmacal MG217 eczema cream recalled for Staphylococcus aureus contamination
MG217 eczema cream recalled for bacterial contamination
Pharmacal recalled one lot of MG217 Multi-Symptom Treatment Cream & Skin Protectant Eczema Cream (6oz tube, lot 1024088) because it was found to contain Staphylococcus aureus bacteria. The contaminated product could cause infections ranging from localized skin infections to serious conditions like sepsis, especially in people with weakened immune systems or compromised skin. No illnesses have been reported so far.
- Check if you have lot 1024088 (found on the crimped end of the tube; expiration November 2026).
- Stop using the product and discard it.
- Contact your doctor if you have used this cream and developed signs of infection (redness, warmth, swelling, drainage, or fever).
- Call Pharmacal at 800-558-6614 (Mon–Fri, 8am–5pm CT) with questions.
Product photos
- May/8/2026- Jackson, WI, Pharmacal is recalling one lot of MG217 Multi-symptom Treatment Cream & Skin Protectant Eczema Cream, 6oz tube to the consumer level. The product has been found to be contaminated with Staphylococcus aureus.
Official notice
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/pharmacal-issues-nationwide-recall-mg217-multi-symptom-treatment-cream-skin-protectant-eczema-creamDon't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief